España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
SPDR Series Trust SPDR S&P Biotech ETF
XBI
ARCA
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$90.51
0.00050
0.00%
Pre-Market: 7:58 PM EDT
Get Report
Comment
Overview
News
Holdings
Dividends
Short Interest
Latest news for SPDR Series Trust SPDR S&P Biotech ETF (ARCA:XBI)
SPDR Series Trust SPDR S&P Biotech ETF (ARCA: XBI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, January 17, 2025
'Buy Long Duration Bonds,' Says Bank Of America Strategist: 4 ETFs To Watch As Trump's Deficit Fight Unfolds
Piero Cingari
Wednesday, January 08, 2025
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Chandrima Sanyal
Wednesday, December 18, 2024
20 ETFs Primed For Unusually Big Swings On Fed Meeting Days
Piero Cingari
Monday, December 16, 2024
Live On CNBC, Joe Terranova Announces Sold SP...
Benzinga Newsdesk
Monday, November 18, 2024
A Must See Chart For Prudent Investors, Trump To Help Tesla Dominate, Nvidia Heat Problem
The Arora Report
Monday, August 19, 2024
On CNBC, Joe Terranova Announces Sold SPDR Se...
Benzinga Newsdesk
Wednesday, July 31, 2024
Should You Invest in the iShares Biotechnology ETF?
Zacks
Monday, July 29, 2024
CNBC Halftime Report Final Trades: Amazon.com...
Benzinga Newsdesk
Monday, July 01, 2024
Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
Piero Cingari
Monday, June 24, 2024
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
Shanthi Rexaline
Wednesday, June 12, 2024
Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
Piero Cingari
Tuesday, June 04, 2024
American Express, Trade Desk And More: CNBC's 'Final Trades'
Avi Kapoor
Monday, June 03, 2024
CNBC Halftime Report Final Trades: American E...
Benzinga Newsdesk
Thursday, May 09, 2024
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Shanthi Rexaline
Thursday, April 04, 2024
Clean Energy, Semiconductors Among Interest-Rate-Sensitive Sectors Hammered Thursday Afternoon On Rate Cut Concerns
Aaron Bry
Wednesday, February 28, 2024
Biotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue?
Erica Kollmann
Opportunities For Investors Beyond AI And Nvidia – Biotech Breaks Out, New GDP Data Shows Inflation Pressure
The Arora Report
Monday, January 08, 2024
5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
Shanthi Rexaline
Wednesday, January 03, 2024
Satori Fund's Dan Niles Names Amazon, Meta Top Stocks To Own In 2024
Adam Eckert
Thursday, December 21, 2023
Top 7 Trending Stocks On WallStreetBets As Of...
Benzinga Newsdesk
Thursday, December 14, 2023
US Stocks Eye 7-Day Winning Streak As Mortgage Rates Fall Below 7%, Yields Tumble: What's Driving Markets Thursday?
Piero Cingari
Wednesday, December 13, 2023
Stocks Hold Steady, Yields Decline As Fed Meeting Looms: What's Driving Markets Wednesday?
Piero Cingari
Monday, December 04, 2023
Fed Rate Cut Speculations Rattle Stocks, Commodities Slide, Bitcoin Shines: What's Driving Markets Monday?
Piero Cingari
Friday, December 01, 2023
Stocks, Gold, Bonds Rally Further, Dollars Tumbles As Traders Anticipate Fed Cuts: What's Driving Markets Friday?
Piero Cingari
Thursday, November 30, 2023
S&P 500, Nasdaq Slip As Tech Underperforms, Oil Reacts to OPEC+: What's Driving Markets Thursday?
Piero Cingari
Wednesday, November 29, 2023
Stocks Drift Higher On Stronger GDP Data, Oil Rebounds As OPEC+ Mulls Cuts: What's Driving Markets Wednesday?
Piero Cingari
Tuesday, November 28, 2023
US Stocks Rebound As Treasury Yields, Dollar Fall On Dovish Fed Remarks, Gold Hits $2,040: What's Driving Markets Tuesday?
Piero Cingari
Friday, September 08, 2023
EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug
Shanthi Rexaline
Friday, August 25, 2023
If You Invested $1000 In Vivek Ramaswamy-Founded Roivant When He Declared Presidential Bid, Here's How Much You'd Have Now
Shanthi Rexaline
Wednesday, June 28, 2023
ETF Returns: Mid-Cap Winners And Losers
Johnny Rice
Sunday, April 30, 2023
Here Are The Best-Performing Industry ETFs And Major Stock Contributors In April
Piero Cingari
Thursday, April 20, 2023
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
Ryan Glosier
Friday, April 14, 2023
Thermo Fisher, Principal Financial Group, And Two Promising ETFs Steal The Show On CNBC's 'Final Trades'
Lisa Levin
Thursday, April 13, 2023
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
Vandana Singh
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
Vandana Singh
Wednesday, April 12, 2023
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
Vandana Singh
Tuesday, April 11, 2023
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
Vandana Singh
Thursday, April 06, 2023
FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
Vandana Singh
Friday, March 31, 2023
Top 5 Best And Worst U.S. Industry ETFs In Q1 2023: AI and Bank Turmoil Shaped Stock Returns
Piero Cingari
Thursday, March 16, 2023
US Judge Weighs Nationwide Ban On Abortion Pills
Vandana Singh
Monday, March 13, 2023
Silicon Valley Bank Meltdown Hits Healthcare Sector As Well
Vandana Singh
Friday, March 10, 2023
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
Vandana Singh
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities
Vandana Singh
Wednesday, March 01, 2023
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
Vandana Singh
Tuesday, January 31, 2023
Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades'
Lisa Levin
Tuesday, December 27, 2022
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
Shanthi Rexaline
Friday, December 02, 2022
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
Shanthi Rexaline
Thursday, December 01, 2022
BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
Faith Ashmore
-
Sponsored
Tuesday, November 22, 2022
The 10 Most Shorted ETFs: Which Sectors Saw Short Interest Increase?
Chris Katje
Monday, November 21, 2022
Devon Energy, Service Now, WR Berkley And This Biotech Play On CNBC's 'Final Trades'
Priya Nigam
Show More
